COVID-19唾液スクリーニング検査の可能性の世界市場レポート 2025年

COVID-19唾液スクリーニング検査の可能性市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.5％で、61億7,000万米ドルに成長します。予測期間の成長は、スクリーニングプログラムとの統合、規制当局の支援、迅速なポイントオブケアCOVID-19検査に対する需要の高まり、人口の増加、eコマースの台頭などに起因すると考えられます。予測期間における主な動向としては、ヘルスケア以外の環境での採用の増加、デジタルヘルスプラットフォームとの統合、次世代技術の出現、技術の進歩、戦略的パートナーシップなどが挙げられます。

ヘルスケア支出の増加は、今後数年間のCOVID-19唾液スクリーニング検査市場の拡大を促進すると予想されます。ヘルスケア支出には、処方薬、入院、医師の診察、医療機器、公衆衛生への取り組みなど、ヘルスケア関連の製品やサービスに対するすべての支出が含まれます。ヘルスケア支出の増加は、低侵襲手術、高度診断技術、新薬の研究開発の増加、ヘルスケアサービスの利用拡大、特殊薬剤の使用などの要因によってもたらされます。ヘルスケア支出の増加は、COVID-19唾液スクリーニング検査の潜在能力を十分に活用するために必要なリソースを提供し、より効果的なパンデミック管理と公衆衛生の成果の向上につながります。例えば、国家統計局によると、2022年の英国のヘルスケア支出は約3,548億8,000万米ドル（2,830億ポンド）に達し、2021年と比較して0.7％の微増となりました。したがって、ヘルスケア支出の増加がCOVID-19唾液スクリーニング検査市場の成長を促進しています。

COVID-19唾液スクリーニング検査市場の主なプレーヤーは、ヘルスケアプロバイダー、検査室、公衆衛生当局間のリアルタイムのコミュニケーションとコラボレーションを改善するために、データ共有プラットフォームなどの革新的な技術の開発に注力しています。これにより、パンデミック時の検査、追跡、対応作業の効率と精度が向上します。データ共有プラットフォームは、ヘルスケアプロバイダー、研究者、組織など様々な利害関係者間で安全なデータ交換を可能にするデジタルシステムです。コラボレーションを促進し、情報へのアクセスを容易にすることで、セクターを超えた意思決定、効率、成果を向上させる。例えば、2024年5月、米国の医療ネットワークであるマウントサイナイ・ヘルスシステムは、ヘルスケア準備センターを立ち上げました。このセンターは、公衆衛生の緊急対応戦略の強化に重点を置き、パンデミックや自然災害などの大規模な危機にヘルスケアシステムが効果的に対処できるようにすることを目的としています。同センターは、マウントサイナイ保健システムの能力を強化し、地域や連邦政府のパートナーと協力して、包括的な準備計画を策定することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のCOVID-19唾液スクリーニング検査の可能性 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のCOVID-19唾液スクリーニング検査の可能性市場：成長率分析
• 世界のCOVID-19唾液スクリーニング検査の可能性市場の実績：規模と成長, 2019-2024
• 世界のCOVID-19唾液スクリーニング検査の可能性市場の予測：規模と成長, 2024-2029, 2034F
• 世界のCOVID-19唾液スクリーニング検査の可能性総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のCOVID-19唾液スクリーニング検査の可能性市場場所別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 旅行駅
• スポーツアリーナ
• エンターテイメント会場
• 企業キャンパス環境
• 大学とカレッジ
• 工場
• その他の場所
• 世界のCOVID-19唾液スクリーニング検査の可能性市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蛍光標識抗原
• RT-PCR
• CRISPR-Cas9
• 世界のCOVID-19唾液スクリーニング検査の可能性市場テストモード別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 集中テスト
• 分散型テスト
• 世界のCOVID-19唾液スクリーニング検査の可能性市場、旅行駅の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 空港
• 鉄道駅
• バスターミナル
• 港湾
• 世界のCOVID-19唾液スクリーニング検査の可能性市場スポーツアリーナの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• スタジアム
• アリーナ
• イベントホール
• 世界のCOVID-19唾液スクリーニング検査の可能性市場エンターテイメント会場の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 劇場
• コンサートホール
• 遊園地
• ナイトクラブ
• 世界のCOVID-19唾液スクリーニング検査の可能性市場企業キャンパス環境の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オフィス
• 企業キャンパス
• ビジネスパーク
• 世界のCOVID-19唾液スクリーニング検査の可能性市場大学の種類別細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高等教育キャンパス
• 調査機関
• 学生寮エリア
• 世界のCOVID-19唾液スクリーニング検査の可能性市場工場の種類別細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製造工場
• 生産設備
• 工業用地
• 世界のCOVID-19唾液スクリーニング検査の可能性市場、その他の場所のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヘルスケア施設
• 政府庁舎
• 公共交通ハブ
• ショッピングセンター
• その他の公共または私的な会場

第7章 地域別・国別分析

• 世界のCOVID-19唾液スクリーニング検査の可能性市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のCOVID-19唾液スクリーニング検査の可能性市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• COVID-19唾液スクリーニング検査の可能性市場：競合情勢
• COVID-19唾液スクリーニング検査の可能性市場：企業プロファイル
  • Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• University of North Carolina at Chapel Hill
• Hologic Inc.
• Beaumont Health
• PerkinElmer Inc.
• Quidel Corporation
• University of Illinois at Urbana-Champaign
• Cepheid
• Seegene Inc.
• ARUP Laboratories
• Vatic Health Limited
• Ambry Genetics Corporation
• LumiraDx Ltd.
• Yale School of Public Health
• Gravity Diagnostics
• Psomagen Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• COVID-19唾液スクリーニング検査の可能性市場2029：新たな機会を提供する国
• COVID-19唾液スクリーニング検査の可能性市場2029：新たな機会を提供するセグメント
• COVID-19唾液スクリーニング検査の可能性市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The potential of saliva-based COVID-19 screening tests pertains to the possible benefits and capabilities they offer in comparison to conventional methods such as nasopharyngeal or oropharyngeal swab tests for detecting the SARS-CoV-2 virus, which causes COVID-19. This potential encompasses enhancements in testing accessibility, patient acceptance, cost-effectiveness, and safety, while also facilitating the adoption of new testing strategies and approaches for better management of the pandemic.

Key locations where the potential of COVID-19 saliva screening tests is prominent include travel stations, sports arenas, entertainment venues, corporate campuses, universities and colleges, factories, and similar settings. Travel stations are specifically designated areas within transportation hubs where individuals can undergo COVID-19 saliva screening tests before commencing their journeys. These tests utilize various technologies such as fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9, with testing conducted through centralized or decentralized approaches.

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

The growing healthcare expenditure is expected to drive the expansion of the COVID-19 saliva screening test market in the coming years. Healthcare expenditure includes all spending on healthcare-related products and services, such as prescription medications, hospital stays, doctor visits, medical equipment, and public health initiatives. The rise in healthcare expenditure is driven by factors like minimally invasive surgeries, advanced diagnostic technologies, increased research and development for new drugs, greater utilization of healthcare services, and the use of specialty medications. Higher healthcare spending provides the resources needed to fully leverage the potential of COVID-19 saliva screening tests, leading to more effective pandemic management and improved public health outcomes. For example, in 2022, according to the Office for National Statistics, the UK's healthcare expenditure reached around $354.88 billion (£283 billion), marking a slight increase of 0.7% compared to 2021. Therefore, the increase in healthcare expenditure is fueling the growth of the COVID-19 saliva screening test market.

Key players in the COVID-19 saliva screening test market are focusing on developing innovative technologies, such as data-sharing platforms, to improve real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This helps enhance the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable secure data exchange between various stakeholders, including healthcare providers, researchers, and organizations. They promote collaboration and facilitate access to information, thereby improving decision-making, efficiency, and outcomes across sectors. For example, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center is focused on enhancing strategies for public health emergency response, ensuring that healthcare systems can effectively manage large-scale crises, such as pandemics or natural disasters. It aims to strengthen the capacity of the Mount Sinai Health System and work with local, regional, and federal partners to develop comprehensive preparedness plans.

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. Through this acquisition, Hologic, Inc. aims to broaden its portfolio of innovative healthcare solutions and expand its presence in the women's health market. Endomagnetics Ltd. is a UK-based medical technology company that develops devices designed to detect cancerous lymph nodes during surgery.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Saliva Screening Test Potential Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 saliva screening test potential market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for covid-19 saliva screening test potential ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 saliva screening test potential market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
• 2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
• 3) By Mode Of Testing: Centralized Testing; Decentralized Testing
• Subsegments:
• 1) By Travel Stations: Airports; Train Stations; Bus Stations; Seaports
• 2) By Sports Arenas: Stadiums; Arenas; Event Halls
• 3) By Entertainment Venues: Theaters; Concert Halls; Amusement Parks; Nightclubs
• 4) By Corporate Campus Environments: Offices; Corporate Campuses; Business Parks
• 5) By Universities And Colleges: Higher Education Campuses; Research Institutions; Student Housing Areas
• 6) By Factories: Manufacturing Plants; Production Facilities; Industrial Sites
• 7) By Other Locations: Healthcare Facilities; Government Buildings; Public Transportation Hubs; Shopping Centers; Other Public Or Private Venues
• Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. COVID-19 Saliva Screening Test Potential market Characteristics

3. COVID-19 Saliva Screening Test Potential market Trends And Strategies

4. COVID-19 Saliva Screening Test Potential market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global COVID-19 Saliva Screening Test Potential Growth Analysis And Strategic Analysis Framework

• 5.1. Global COVID-19 Saliva Screening Test Potential PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global COVID-19 Saliva Screening Test Potential market Growth Rate Analysis
• 5.4. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global COVID-19 Saliva Screening Test Potential Total Addressable Market (TAM)

6. COVID-19 Saliva Screening Test Potential market Segmentation

• 6.1. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities And Colleges
• Factories
• Other Locations
• 6.2. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescence-Labelled Antigen
• RT-PCR
• CRISPR-Cas9
• 6.3. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centralized Testing
• Decentralized Testing
• 6.4. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Airports
• Train Stations
• Bus Stations
• Seaports
• 6.5. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stadiums
• Arenas
• Event Halls
• 6.6. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Theaters
• Concert Halls
• Amusement Parks
• Nightclubs
• 6.7. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Offices
• Corporate Campuses
• Business Parks
• 6.8. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Higher Education Campuses
• Research Institutions
• Student Housing Areas
• 6.9. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manufacturing Plants
• Production Facilities
• Industrial Sites
• 6.10. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Healthcare Facilities
• Government Buildings
• Public Transportation Hubs
• Shopping Centers
• Other Public Or Private Venues

7. COVID-19 Saliva Screening Test Potential market Regional And Country Analysis

• 7.1. Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific COVID-19 Saliva Screening Test Potential market

• 8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China COVID-19 Saliva Screening Test Potential market

• 9.1. China COVID-19 Saliva Screening Test Potential market Overview
• 9.2. China COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India COVID-19 Saliva Screening Test Potential market

• 10.1. India COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan COVID-19 Saliva Screening Test Potential market

• 11.1. Japan COVID-19 Saliva Screening Test Potential market Overview
• 11.2. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia COVID-19 Saliva Screening Test Potential market

• 12.1. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia COVID-19 Saliva Screening Test Potential market

• 13.1. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea COVID-19 Saliva Screening Test Potential market

• 14.1. South Korea COVID-19 Saliva Screening Test Potential market Overview
• 14.2. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe COVID-19 Saliva Screening Test Potential market

• 15.1. Western Europe COVID-19 Saliva Screening Test Potential market Overview
• 15.2. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK COVID-19 Saliva Screening Test Potential market

• 16.1. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany COVID-19 Saliva Screening Test Potential market

• 17.1. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France COVID-19 Saliva Screening Test Potential market

• 18.1. France COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy COVID-19 Saliva Screening Test Potential market

• 19.1. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain COVID-19 Saliva Screening Test Potential market

• 20.1. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe COVID-19 Saliva Screening Test Potential market

• 21.1. Eastern Europe COVID-19 Saliva Screening Test Potential market Overview
• 21.2. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia COVID-19 Saliva Screening Test Potential market

• 22.1. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America COVID-19 Saliva Screening Test Potential market

• 23.1. North America COVID-19 Saliva Screening Test Potential market Overview
• 23.2. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA COVID-19 Saliva Screening Test Potential market

• 24.1. USA COVID-19 Saliva Screening Test Potential market Overview
• 24.2. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada COVID-19 Saliva Screening Test Potential market

• 25.1. Canada COVID-19 Saliva Screening Test Potential market Overview
• 25.2. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America COVID-19 Saliva Screening Test Potential market

• 26.1. South America COVID-19 Saliva Screening Test Potential market Overview
• 26.2. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil COVID-19 Saliva Screening Test Potential market

• 27.1. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East COVID-19 Saliva Screening Test Potential market

• 28.1. Middle East COVID-19 Saliva Screening Test Potential market Overview
• 28.2. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa COVID-19 Saliva Screening Test Potential market

• 29.1. Africa COVID-19 Saliva Screening Test Potential market Overview
• 29.2. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. COVID-19 Saliva Screening Test Potential market Competitive Landscape And Company Profiles

• 30.1. COVID-19 Saliva Screening Test Potential market Competitive Landscape
• 30.2. COVID-19 Saliva Screening Test Potential market Company Profiles
  • 30.2.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. COVID-19 Saliva Screening Test Potential market Other Major And Innovative Companies

• 31.1. University of North Carolina at Chapel Hill
• 31.2. Hologic Inc.
• 31.3. Beaumont Health
• 31.4. PerkinElmer Inc.
• 31.5. Quidel Corporation
• 31.6. University of Illinois at Urbana-Champaign
• 31.7. Cepheid
• 31.8. Seegene Inc.
• 31.9. ARUP Laboratories
• 31.10. Vatic Health Limited
• 31.11. Ambry Genetics Corporation
• 31.12. LumiraDx Ltd.
• 31.13. Yale School of Public Health
• 31.14. Gravity Diagnostics
• 31.15. Psomagen Inc.

32. Global COVID-19 Saliva Screening Test Potential market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential market

34. Recent Developments In The COVID-19 Saliva Screening Test Potential market

35. COVID-19 Saliva Screening Test Potential market High Potential Countries, Segments and Strategies

• 35.1 COVID-19 Saliva Screening Test Potential market In 2029 - Countries Offering Most New Opportunities
• 35.2 COVID-19 Saliva Screening Test Potential market In 2029 - Segments Offering Most New Opportunities
• 35.3 COVID-19 Saliva Screening Test Potential market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer